Picture of IntegraGen SA logo

ALINT — IntegraGen SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Integragen FY Operating Loss Narrows To 0.4 Million Euros

April 3 (Reuters) - Integragen SA  ALINT.PA :
    * 2020 OUTLOOK: CASH AVAILABLE WILL BE USED TO FINANCE
OPERATIONAL
AND INVESTMENT REQUIREMENTS
    * FY NET LOSS EUR 0.3 MILLION VERSUS LOSS OF EUR 1.1 MILLION
YEAR
AGO
    * FY OPERATING LOSS EUR 0.4 MILLION VERSUS LOSS OF EUR 1.2
MILLION
YEAR AGO
    * NET CASH AND CASH EQUIVALENTS AT THE END OF 2019 AMOUNTED
TO
€2.7 MILLION COMPARED TO €3.9 MILLION AT THE END OF 2018
    * OUTLOOK 2020 : THE SEQOIA PROJECT IS EXPECTED TO GENERATE
A
MINIMUM TURNOVER OF € 2,700 K, AND THEREFORE ANTICIPATES, AT
THIS STAGE, A STRONG GROWTH IN TURNOVER FOR THE FINANCIAL YEAR
    * ON CORONAVIRUS:  THE TEAM BASED AT THE EVRY LABORATORY AND
THE
ONE BASED AT THE PASTEUR INSTITUTE CONTINUE THEIR ACTIVITIES
    * IMPLEMENTATION OF BUSINESS CONTINUITY MEASURES DURING THE
COVID-19 PANDEMIC
    * 2020 OUTLOOK: ALSO EXPECTS INCREASED SALES OF SEQUENCING
DATA
INTERPRETATION SOFTWARE (SIRIUS™, MERCURY™ET GALILEO™) IN SAAS
(SOFTWARE AS A SERVICE) MODE
    * THE STABILITY OF THE COMPANY'S BUSINESS MODEL SHOULD
ENABLE
INTEGRAGEN TO RESUME ITS ACTIVITY AND RECOVER MOST OF THE LACK
OF ACTIVITY RECORDED DURING THE PANDEMIC
    * CONTRACT WITH THE INSTITUT PASTEUR HAS BEEN EXTENDED UNTIL
DECEMBER 2021, BASED ON AN INCREASED LEVEL OF PERFORMANC

Source text for Eikon:  ID:nNDLc5Y5qk 
Further company coverage:  ALINT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on IntegraGen SA

See all news